{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:55:07Z","timestamp":1793048107860,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T00:00:00Z","timestamp":1340150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00262-012-1291-8","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T17:01:43Z","timestamp":1340125303000},"page":"2333-2342","source":"Crossref","is-referenced-by-count":16,"title":["Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis"],"prefix":"10.1007","volume":"61","author":[{"given":"Fenella J.","family":"Rich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn J.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquie L.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Ronchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna R.","family":"Kirman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,20]]},"reference":[{"key":"1291_CR1","doi-asserted-by":"crossref","unstructured":"Coley WB (1910) The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med 3 (Surg Sect):1\u201348","DOI":"10.1177\/003591571000301601"},{"issue":"39","key":"1291_CR2","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1016\/j.vaccine.2008.06.092","volume":"26","author":"JM Grange","year":"2008","unstructured":"Grange JM, Bottasso O, Stanford CA, Stanford JL (2008) The use of mycobacterial adjuvant-based agents for immunotherapy of cancer. Vaccine 26(39):4984\u20134990. doi: 10.1016\/j.vaccine.2008.06.092","journal-title":"Vaccine"},{"key":"1291_CR3","doi-asserted-by":"crossref","first-page":"405310","DOI":"10.1155\/2011\/405310","volume":"2011","author":"J Kleinnijenhuis","year":"2011","unstructured":"Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R (2011) Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol 2011:405310. doi: 10.1155\/2011\/405310","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"1291_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QCO.0b013e3282f88b5d","volume":"21","author":"EK Jo","year":"2008","unstructured":"Jo EK (2008) Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis 21(3):279\u2013286. doi: 10.1097\/QCO.0b013e3282f88b5d","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"1291_CR5","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","volume":"68","author":"S Tsuji","year":"2000","unstructured":"Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A, Toyoshima K, Seya T (2000) Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect Immun 68(12):6883\u20136890","journal-title":"Infect Immun"},{"issue":"4","key":"1291_CR6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PPO.0b013e3181eaca65","volume":"16","author":"S Gnjatic","year":"2010","unstructured":"Gnjatic S, Sawhney NB, Bhardwaj N (2010) Toll-like receptor agonists: are they good adjuvants? Cancer J 16(4):382\u2013391. doi: 10.1097\/PPO.0b013e3181eaca65","journal-title":"Cancer J"},{"issue":"2","key":"1291_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116(2):180\u2013183","journal-title":"J Urol"},{"issue":"6","key":"1291_CR8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","volume":"59","author":"M Babjuk","year":"2011","unstructured":"Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J, Roupret M (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59(6):997\u20131008. doi: 10.1016\/j.eururo.2011.03.017","journal-title":"Eur Urol"},{"issue":"3","key":"1291_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ctrv.2009.12.005","volume":"36","author":"MD Shelley","year":"2010","unstructured":"Shelley MD, Mason MD, Kynaston H (2010) Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 36(3):195\u2013205. doi: 10.1016\/j.ctrv.2009.12.005","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"1291_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","volume":"91","author":"RF Bevers","year":"2004","unstructured":"Bevers RF, Kurth KH, Schamhart DH (2004) Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br J Cancer 91(4):607\u2013612. doi: 10.1038\/sj.bjc.6602026","journal-title":"Br J Cancer"},{"issue":"6","key":"1291_CR11","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.eururo.2009.01.040","volume":"55","author":"C Ayari","year":"2009","unstructured":"Ayari C, LaRue H, Hovington H, Decobert M, Harel F, Bergeron A, Tetu B, Lacombe L, Fradet Y (2009) Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guerin immunotherapy. Eur Urol 55(6):1386\u20131395. doi: 10.1016\/j.eururo.2009.01.040","journal-title":"Eur Urol"},{"issue":"8","key":"1291_CR12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00262-008-0643-x","volume":"58","author":"T Higuchi","year":"2009","unstructured":"Higuchi T, Shimizu M, Owaki A, Takahashi M, Shinya E, Nishimura T, Takahashi H (2009) A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth. Cancer Immunol Immunother 58(8):1245\u20131255. doi: 10.1007\/s00262-008-0643-x","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"1291_CR13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1464-410X.2004.05176.x","volume":"94","author":"JD Beatty","year":"2004","unstructured":"Beatty JD, Islam S, North ME, Knight SC, Ogden CW (2004) Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer? BJU Int 94(9):1377\u20131383. doi: 10.1111\/j.1464-410X.2004.05176.x","journal-title":"BJU Int"},{"issue":"4","key":"1291_CR14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ijc.20442","volume":"112","author":"SL Young","year":"2004","unstructured":"Young SL, Murphy M, Zhu XW, Harnden P, O\u2019Donnell MA, James K, Patel PM, Selby PJ, Jackson AM (2004) Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy. Int J Cancer 112(4):653\u2013660. doi: 10.1002\/ijc.20442","journal-title":"Int J Cancer"},{"key":"1291_CR15","author":"S Rakshit","year":"2011","unstructured":"Rakshit S, Ponnusamy M, Papanna S, Saha B, Ahmed A, Nandi D (2011) Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFNgamma. Int J Cancer. doi: 10.1002\/ijc.26099","journal-title":"Int J Cancer"},{"key":"1291_CR16","author":"J Stebbing","year":"2011","unstructured":"Stebbing J, Dalgleish A, Gifford-Moore A, Martin A, Gleeson C, Wilson G, Brunet LR, Grange J, Mudan S (2011) An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma. Ann Oncol. doi: 10.1093\/annonc\/mdr363","journal-title":"Ann Oncol"},{"issue":"2","key":"1291_CR17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejca.2007.08.021","volume":"44","author":"JL Stanford","year":"2008","unstructured":"Stanford JL, Stanford CA, O\u2019Brien ME, Grange JM (2008) Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung. Eur J Cancer 44(2):224\u2013227. doi: 10.1016\/j.ejca.2007.08.021","journal-title":"Eur J Cancer"},{"issue":"2","key":"1291_CR18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejca.2007.11.003","volume":"44","author":"PM Patel","year":"2008","unstructured":"Patel PM, Sim S, O\u2019Donnell DO, Protheroe A, Beirne D, Stanley A, Tourani JM, Khayat D, Hancock B, Vasey P, Dalgleish A, Johnston C, Banks RE, Selby PJ (2008) An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer. Eur J Cancer 44(2):216\u2013223. doi: 10.1016\/j.ejca.2007.11.003","journal-title":"Eur J Cancer"},{"issue":"3","key":"1291_CR19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/iai.28.3.887-892.1980","volume":"28","author":"E Yarkoni","year":"1980","unstructured":"Yarkoni E, Rapp HJ (1980) Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis. Infect Immun 28(3):887\u2013892","journal-title":"Infect Immun"},{"issue":"6","key":"1291_CR20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0092-8674(88)91043-4","volume":"54","author":"MW Moore","year":"1988","unstructured":"Moore MW, Carbone FR, Bevan MJ (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54(6):777\u2013785","journal-title":"Cell"},{"issue":"1","key":"1291_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1189\/jlb.0809548","volume":"88","author":"M Rosas","year":"2010","unstructured":"Rosas M, Thomas B, Stacey M, Gordon S, Taylor PR (2010) The myeloid 7\/4-antigen defines recently generated inflammatory macrophages and is synonymous with Ly-6B. J Leukoc Biol 88(1):169\u2013180. doi: 10.1189\/jlb.0809548","journal-title":"J Leukoc Biol"},{"issue":"4","key":"1291_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.smim.2005.05.013","volume":"17","author":"B Leon","year":"2005","unstructured":"Leon B, Lopez-Bravo M, Ardavin C (2005) Monocyte-derived dendritic cells. Semin Immunol 17(4):313\u2013318. doi: 10.1016\/j.smim.2005.05.013","journal-title":"Semin Immunol"},{"issue":"5966","key":"1291_CR23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","volume":"327","author":"F Geissmann","year":"2010","unstructured":"Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327(5966):656\u2013661. doi: 10.1126\/science.1178331","journal-title":"Science"},{"issue":"4","key":"1291_CR24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0302-2838(03)00371-3","volume":"44","author":"RJ Sylvester","year":"2003","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Hoeltl W, Bono AV (2003) The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy: results from a European organisation for research and treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol 44(4):423\u2013428","journal-title":"Eur Urol"},{"issue":"5","key":"1291_CR25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinids\/24.5.982","volume":"24","author":"C Pierre-Audigier","year":"1997","unstructured":"Pierre-Audigier C, Jouanguy E, Lamhamedi S, Altare F, Rauzier J, Vincent V, Canioni D, Emile JF, Fischer A, Blanche S, Gaillard JL, Casanova JL (1997) Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis 24(5):982\u2013984","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1291_CR26","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","volume":"168","author":"DR Roach","year":"2002","unstructured":"Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168(9):4620\u20134627","journal-title":"J Immunol"},{"issue":"2","key":"1291_CR27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/IAI.73.2.784-794.2005","volume":"73","author":"EJ Cheadle","year":"2005","unstructured":"Cheadle EJ, O\u2019Donnell D, Selby PJ, Jackson AM (2005) Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cells. Infect Immun 73(2):784\u2013794. doi: 10.1128\/IAI.73.2.784-794.2005","journal-title":"Infect Immun"},{"issue":"4","key":"1291_CR28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.immuni.2007.01.017","volume":"26","author":"B Leon","year":"2007","unstructured":"Leon B, Lopez-Bravo M, Ardavin C (2007) Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26(4):519\u2013531. doi: 10.1016\/j.immuni.2007.01.017","journal-title":"Immunity"},{"issue":"4","key":"1291_CR29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ni.1707","volume":"10","author":"H Nakano","year":"2009","unstructured":"Nakano H, Lin KL, Yanagita M, Charbonneau C, Cook DN, Kakiuchi T, Gunn MD (2009) Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat Immunol 10(4):394\u2013402. doi: 10.1038\/ni.1707","journal-title":"Nat Immunol"},{"issue":"2","key":"1291_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","volume":"24","author":"M Borgne Le","year":"2006","unstructured":"Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, Caux C, Ait-Yahia S, Vicari A, Kaiserlian D, Dubois B (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24(2):191\u2013201. doi: 10.1016\/j.immuni.2006.01.005","journal-title":"Immunity"},{"issue":"48","key":"1291_CR31","doi-asserted-by":"crossref","first-page":"20377","DOI":"10.1073\/pnas.0910295106","volume":"106","author":"E Segura","year":"2009","unstructured":"Segura E, Albiston AL, Wicks IP, Chai SY, Villadangos JA (2009) Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc Natl Acad Sci USA 106(48):20377\u201320381. doi: 10.1073\/pnas.0910295106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1291_CR32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.194.9.1361","volume":"194","author":"RT Palframan","year":"2001","unstructured":"Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, von Andrian UH (2001) Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 194(9):1361\u20131373","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"1291_CR33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tube.2004.09.006","volume":"85","author":"R Reljic","year":"2005","unstructured":"Reljic R, Di Sano C, Crawford C, Dieli F, Challacombe S, Ivanyi J (2005) Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis (Edinb) 85(1\u20132):81\u201388. doi: 10.1016\/j.tube.2004.09.006","journal-title":"Tuberculosis (Edinb)"},{"issue":"10","key":"1291_CR34","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1172\/JCI45113","volume":"121","author":"HA Schreiber","year":"2011","unstructured":"Schreiber HA, Harding JS, Hunt O, Altamirano CJ, Hulseberg PD, Stewart D, Fabry Z, Sandor M (2011) Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 121(10):3902\u20133913. doi: 10.1172\/JCI45113","journal-title":"J Clin Invest"},{"issue":"11","key":"1291_CR35","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00262-008-0487-4","volume":"57","author":"P Stoitzner","year":"2008","unstructured":"Stoitzner P, Green LK, Jung JY, Price KM, Atarea H, Kivell B, Ronchese F (2008) Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells. Cancer Immunol Immunother 57(11):1665\u20131673. doi: 10.1007\/s00262-008-0487-4","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1291_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4049\/jimmunol.181.1.155","volume":"181","author":"MY Gerner","year":"2008","unstructured":"Gerner MY, Casey KA, Mescher MF (2008) Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses. J Immunol 181(1):155\u2013164. doi: 181\/1\/155","journal-title":"J Immunol"},{"issue":"5","key":"1291_CR37","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.4049\/jimmunol.0803479","volume":"182","author":"MY Gerner","year":"2009","unstructured":"Gerner MY, Mescher MF (2009) Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells. J Immunol 182(5):2726\u20132737. doi: 10.4049\/jimmunol.0803479","journal-title":"J Immunol"},{"issue":"3","key":"1291_CR38","doi-asserted-by":"crossref","first-page":"e17515","DOI":"10.1371\/journal.pone.0017515","volume":"6","author":"H Ataera","year":"2011","unstructured":"Ataera H, Hyde E, Price KM, Stoitzner P, Ronchese F (2011) Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells. PLoS One 6(3):e17515. doi: 10.1371\/journal.pone.0017515","journal-title":"PLoS One"},{"issue":"7378","key":"1291_CR39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480(7378):480\u2013489. doi: 10.1038\/nature10673","journal-title":"Nature"},{"issue":"11","key":"1291_CR40","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.4049\/jimmunol.166.11.6500","volume":"166","author":"BK Helmich","year":"2001","unstructured":"Helmich BK, Dutton RW (2001) The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J Immunol 166(11):6500\u20136508","journal-title":"J Immunol"},{"issue":"5","key":"1291_CR41","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.4049\/jimmunol.177.5.3004","volume":"177","author":"JA Hollenbaugh","year":"2006","unstructured":"Hollenbaugh JA, Dutton RW (2006) IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor. J Immunol 177(5):3004\u20133011. doi: 177\/5\/3004","journal-title":"J Immunol"},{"issue":"5609","key":"1291_CR42","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","volume":"299","author":"C Pasare","year":"2003","unstructured":"Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells. Science 299(5609):1033\u20131036. doi: 10.1126\/science.1078231","journal-title":"Science"},{"issue":"5976","key":"1291_CR43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1126\/science.1186068","volume":"328","author":"A Zanin-Zhorov","year":"2010","unstructured":"Zanin-Zhorov A, Ding Y, Kumari S, Attur M, Hippen KL, Brown M, Blazar BR, Abramson SB, Lafaille JJ, Dustin ML (2010) Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science 328(5976):372\u2013376. doi: 10.1126\/science.1186068","journal-title":"Science"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1291-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-012-1291-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1291-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:15:45Z","timestamp":1642551345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1291-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,20]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1291-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,20]]}}}